Q: What is Welireg used for?

Welireg is used to treat von Hippel-Lindau disease -associated renal cell carcinoma, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors (not requiring immediate surgery).

Q: How does Welireg work?

Mechanism of Action Welireg belongs to a class of medications known as hypoxia-inducible factor 2 alpha (HIF-2α) inhibitors. It works by targeting a specific pathway in the body that regulates how cells respond to low oxygen levels. In a healthy body, a protein called von Hippel-Lindau (VHL) helps manage the levels of another protein called HIF-2α. When the VHL protein is missing or not functioning properly—which occurs in people with VHL disease or certain types of kidney cancer—HIF-2α builds up inside cells. This buildup of HIF-2α triggers the body to produce more proteins that encourage: The rapid growth and division of cancer cells. The formation of new blood vessels that feed tumors. The spread of cancer to other parts of the body. Welireg works by binding directly to HIF-2α. By doing so, it prevents HIF-2α from pairing with other proteins needed to activate the genes responsible for tumor growth. This helps to slow down or stop the growth of tumors and may even cause them to shrink.

Q: What are the active ingredients in Welireg?

The active ingredient in Welireg is belzutifan .

Q: What are the side effects of Welireg?

Common side effects of Welireg may include: Fatigue Anemia Dizziness and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Welireg?

Welireg belongs to the HIF-2 alpha inhibitor drug class.

Q: What is the dosage of Welireg and how do I take it?

How to Take Welireg Welireg is a tablet taken by mouth. It is usually taken once a day at the same time every day. You may take this medication with or without food. When taking Welireg, follow these instructions: Swallow the tablets whole. Do not chew, crush, or break the tablets before swallowing. Missed Doses and Vomiting If you miss a dose of Welireg, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed one. If you vomit after taking a dose, do not take an extra dose to replace it. Wait and take your next scheduled dose the following day.

Q: Is Welireg safe during pregnancy and breastfeeding?

Pregnancy Considerations Welireg may cause harm to a developing fetus if taken during pregnancy. Healthcare providers typically perform a pregnancy test to ensure a patient is not pregnant before starting this medication. If you are pregnant or plan to become pregnant, discuss the potential risks and benefits with your doctor. Contraception Requirements Because of the risks to a fetus, effective birth control is necessary during treatment: For females: Use effective non-hormonal contraception during treatment and for one week after the last dose. Welireg can make hormonal contraceptives, such as birth control pills, implants, or patches, less effective. For males: If you have a female partner who can become pregnant, use effective contraception during treatment and for one week after the last dose. Breastfeeding It is not known if Welireg passes into breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for one week following the final dose. Fertility This medication may impair fertility in both males and females, which could affect the ability to have children in the future.

Q: What forms and strengths does Welireg come in?

Welireg is supplied in the following form: Oral Tablet: This medication is taken by mouth. The tablets should be swallowed whole and should not be broken, crushed, or chewed before swallowing.

Q: What is the FDA approval status of Welireg?

FDA Approval Status Welireg was initially approved by the U.S. Food and Drug Administration (FDA) in 2021. It is classified as a hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor. Approved Uses The FDA has granted approval for Welireg to treat several conditions in adult patients: Von Hippel-Lindau (VHL) disease: For patients requiring therapy for VHL-associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET) that do not require immediate surgery. Advanced Renal Cell Carcinoma: For patients with advanced kidney cancer who have previously received treatment with a PD-1 or PD-L1 inhibitor and a VEGF tyrosine kinase inhibitor. Pheochromocytoma and Paraganglioma: For patients with VHL-associated pheochromocytoma or paraganglioma. Boxed Warning Welireg carries a boxed warning regarding embryo-fetal toxicity. Exposure to the medication during pregnancy can cause fetal harm or loss of pregnancy. Patients are advised of the following regulatory safety requirements: Pregnancy testing is required for individuals of childbearing potential before starting treatment. Effective non-hormonal contraception must be used during treatment and for one week after the final dose. Welireg can make hormonal contraceptives less effective, necessitating the use of alternative birth control methods.

Question 1

What is Welireg?

Accepted Answer

Welireg is a targeted therapy medication that belongs to a class of drugs known as hypoxia-inducible factor-2 alpha (HIF-2α) inhibitors. It works by binding to the HIF-2α protein, which plays a role in how cells manage oxygen levels and can contribute to the development of abnormal growths.

By blocking this specific protein, the medication interferes with the processes that allow certain cells to multiply and form tumors. This mechanism of action helps to manage the progression of specific conditions at the cellular level.

Question 2

What is Welireg used for?

Accepted Answer

Welireg is used to treat von Hippel-Lindau disease-associated renal cell carcinoma, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors (not requiring immediate surgery).

Question 3

How does Welireg work?

Accepted Answer

Mechanism of Action

Welireg belongs to a class of medications known as hypoxia-inducible factor 2 alpha (HIF-2α) inhibitors. It works by targeting a specific pathway in the body that regulates how cells respond to low oxygen levels.

In a healthy body, a protein called von Hippel-Lindau (VHL) helps manage the levels of another protein called HIF-2α. When the VHL protein is missing or not functioning properly—which occurs in people with VHL disease or certain types of kidney cancer—HIF-2α builds up inside cells.

This buildup of HIF-2α triggers the body to produce more proteins that encourage:

The rapid growth and division of cancer cells.
The formation of new blood vessels that feed tumors.
The spread of cancer to other parts of the body.

Welireg works by binding directly to HIF-2α. By doing so, it prevents HIF-2α from pairing with other proteins needed to activate the genes responsible for tumor growth. This helps to slow down or stop the growth of tumors and may even cause them to shrink.

Question 4

What are the active ingredients in Welireg?

Accepted Answer

The active ingredient in Welireg is belzutifan.

Question 5

What are the side effects of Welireg?

Accepted Answer

Common side effects of Welireg may include:

Fatigue
Anemia
Dizziness
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Welireg?

Accepted Answer

Welireg belongs to the HIF-2 alpha inhibitor drug class.

Question 7

What is the dosage of Welireg and how do I take it?

Accepted Answer

How to Take Welireg

Welireg is a tablet taken by mouth. It is usually taken once a day at the same time every day. You may take this medication with or without food.

When taking Welireg, follow these instructions:

Swallow the tablets whole.
Do not chew, crush, or break the tablets before swallowing.

Missed Doses and Vomiting

If you miss a dose of Welireg, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed one.

If you vomit after taking a dose, do not take an extra dose to replace it. Wait and take your next scheduled dose the following day.

Question 8

Is Welireg safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Considerations

Welireg may cause harm to a developing fetus if taken during pregnancy. Healthcare providers typically perform a pregnancy test to ensure a patient is not pregnant before starting this medication. If you are pregnant or plan to become pregnant, discuss the potential risks and benefits with your doctor.

Contraception Requirements

Because of the risks to a fetus, effective birth control is necessary during treatment:

For females: Use effective non-hormonal contraception during treatment and for one week after the last dose. Welireg can make hormonal contraceptives, such as birth control pills, implants, or patches, less effective.
For males: If you have a female partner who can become pregnant, use effective contraception during treatment and for one week after the last dose.

Breastfeeding

It is not known if Welireg passes into breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for one week following the final dose.

Fertility

This medication may impair fertility in both males and females, which could affect the ability to have children in the future.

Question 9

What forms and strengths does Welireg come in?

Accepted Answer

Welireg is supplied in the following form:

Oral Tablet: This medication is taken by mouth.

The tablets should be swallowed whole and should not be broken, crushed, or chewed before swallowing.

Question 10

What is the FDA approval status of Welireg?

Accepted Answer

FDA Approval Status

Welireg was initially approved by the U.S. Food and Drug Administration (FDA) in 2021. It is classified as a hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor.

Approved Uses

The FDA has granted approval for Welireg to treat several conditions in adult patients:

Von Hippel-Lindau (VHL) disease: For patients requiring therapy for VHL-associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET) that do not require immediate surgery.
Advanced Renal Cell Carcinoma: For patients with advanced kidney cancer who have previously received treatment with a PD-1 or PD-L1 inhibitor and a VEGF tyrosine kinase inhibitor.
Pheochromocytoma and Paraganglioma: For patients with VHL-associated pheochromocytoma or paraganglioma.

Boxed Warning

Welireg carries a boxed warning regarding embryo-fetal toxicity. Exposure to the medication during pregnancy can cause fetal harm or loss of pregnancy. Patients are advised of the following regulatory safety requirements:

Pregnancy testing is required for individuals of childbearing potential before starting treatment.
Effective non-hormonal contraception must be used during treatment and for one week after the final dose.
Welireg can make hormonal contraceptives less effective, necessitating the use of alternative birth control methods.

Question 11

What should I know about Welireg and cost?

Accepted Answer

Insurance and Pharmacy Factors

Welireg is a prescription medication, and the out-of-pocket cost can vary significantly based on the following factors:

Insurance Plan: Coverage levels differ between private insurance, Medicare, and Medicaid. The drug's placement on an insurance company's formulary will determine the copayment or coinsurance amount.
Specialty Pharmacy: Because Welireg is used to treat specific types of cancer, it is often dispensed through specialty pharmacies rather than standard retail locations. These pharmacies coordinate with insurance providers to manage the high-cost nature of the treatment.

Financial Assistance

Patients may be able to reduce their costs through various programs:

Manufacturer Assistance: Pharmaceutical companies often provide patient assistance programs or copay savings cards for those who meet specific clinical and financial criteria.
Support Organizations: Some non-profit organizations offer grants or financial aid to help patients cover the costs of cancer treatments.

It is recommended that patients contact their insurance provider or the specialty pharmacy to obtain a precise cost estimate based on their specific coverage.

Welireg

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Welireg

Hospitals.net Disclosure